NASDAQ:ASTH Astrana Health (ASTH) Stock Price, News & Analysis $36.73 -0.15 (-0.41%) Closing price 11/3/2026 04:00 PM EasternExtended Trading$36.00 -0.73 (-1.99%) As of 11/3/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Astrana Health Stock (NASDAQ:ASTH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Astrana Health alerts:Sign Up Key Stats Today's Range$36.17▼$37.5150-Day Range$33.55▼$39.6052-Week Range$18.08▼$51.60Volume379,655 shsAverage Volume291,967 shsMarket Capitalization$2.05 billionP/E Ratio21.82Dividend YieldN/APrice Target$49.88Consensus RatingModerate Buy Company Overview Astrana Health, Inc. (NASDAQ: ASTH), formerly known as Apollo Medical Holdings, is a healthcare enablement company focused on helping providers and health plans deliver coordinated, value-based care. The company combines physician networks, care-management capabilities, technology and data analytics to support improved clinical outcomes and more efficient healthcare delivery. Astrana Health’s services include population health management, physician practice support, utilization management, care coordination and clinical analytics. Through its affiliated medical groups, independent physician associations and care-delivery organizations, the company supports primary care and specialty providers while helping manage the healthcare needs of patients, including those with complex or chronic conditions. The company has historically operated primarily in California and has expanded its platform and healthcare relationships into additional U.S. markets. Astrana Health was established as Apollo Medical Holdings and adopted its current name as part of a broader effort to reflect its integrated healthcare and technology platform. Brandon Sim serves as the company’s chief executive officer.AI Generated. May Contain Errors. Read More Astrana Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks87th Percentile Overall ScoreASTH MarketRank™: 4.35096153846 of 5 starsAstrana Health scored higher than 87% of companies evaluated by MarketBeat, and ranked 130th out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingModerate Buy Consensus RatingAstrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on no strong buy ratings, 8 buy ratings, 2 hold ratings, and no sell ratings.Upside PotentialAstrana Health has a consensus price target of $49.88, representing about 35.8% upside from its current price of $36.73.Amount of Analyst CoverageAstrana Health has only been the subject of 4 research reports in the past 90 days.Read more about Astrana Health's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth41.91% Earnings GrowthEarnings for Astrana Health are expected to grow by 41.91% in the coming year, from $1.36 to $1.93 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Astrana Health is 21.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.58.Price to Earnings Ratio vs. SectorThe P/E ratio of Astrana Health is 21.82, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 36.33.Price to Book Value per Share RatioAstrana Health has a P/B Ratio of 2.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Astrana Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted6.78% of the float of Astrana Health has been sold short.Short Interest Ratio / Days to CoverAstrana Health has a short interest ratio ("days to cover") of 8.85.Change versus previous monthShort interest in Astrana Health has recently decreased by 2.49%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAstrana Health does not currently pay a dividend.Dividend GrowthAstrana Health does not have a long track record of dividend growth. News and Social Media2.3 / 5News Sentiment0.72 News SentimentAstrana Health has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Astrana Health this week, compared to 4 articles on an average week. Company Ownership1.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Astrana Health insiders have not sold or bought any company stock.Percentage Held by Insiders20.30% of the stock of Astrana Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Astrana Health's insider trading history. Receive ASTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ASTH Stock News HeadlinesAstrana Health, Inc. (NASDAQ:ASTH) Stock Rated "Moderate Buy" by Sell-Side BrokeragesNovember 2 at 3:45 AM | americanbankingnews.comDiamond Hill Small Cap Fund Q3 2026 Portfolio ActivityOctober 28, 2026 | seekingalpha.comIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest. A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this fall, one that could offer savings rates up to 6 percent. See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live. | Banyan Hill Publishing (Ad)INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTHOctober 22, 2026 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTHOctober 20, 2026 | globenewswire.comAlignment, Astrana Partner to Expand In-Network Care in CaliforniaOctober 19, 2026 | marketscreener.comMBarclays Sticks to Its Buy Rating for Astrana Health (ASTH)October 18, 2026 | theglobeandmail.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTHOctober 15, 2026 | prnewswire.comSee More Headlines ASTH Stock Analysis - Frequently Asked Questions How have ASTH shares performed this year? Astrana Health's stock was trading at $24.81 on January 1st, 2026. Since then, ASTH shares have increased by 48.0% and is now trading at $36.73. How were Astrana Health's earnings last quarter? Astrana Health, Inc. (NASDAQ:ASTH) announced its quarterly earnings data on Thursday, August, 6th. The company reported $0.80 EPS for the quarter, topping analysts' consensus estimates of $0.34 by $0.46. The business's revenue for the quarter was up 48.5% compared to the same quarter last year. Read the conference call transcript. Who are Astrana Health's major shareholders? Astrana Health's top institutional investors include SteelPeak Wealth LLC (0.78%), NorthCrest Asset Manangement LLC (0.29%), Insight Wealth Strategies LLC (0.25%) and State of Alaska Department of Revenue (0.03%). How do I buy shares of Astrana Health? Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/06/2026Today11/03/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 ASTH's financial health is in the Yellow zone, according to TradeSmith. ASTH has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:ASTH Previous SymbolNASDAQ:ASTH CIK1083446 Webwww.astranahealth.com Phone626-282-0288Fax818-839-5190Employees3,000Year Founded1985Price Target and Rating Average Price Target for Astrana Health$49.88 High Price Target$65.00 Low Price Target$37.00 Potential Upside/Downside+35.8%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)$0.82 Trailing P/E Ratio21.82 Forward P/E Ratio19.03 P/E GrowthN/ANet Income$22.49 million Net Margins1.05% Pretax Margin1.56% Return on Equity10.30% Return on Assets3.67% Debt Debt-to-Equity Ratio1.05 Current Ratio1.23 Quick Ratio1.23 Sales & Book Value Annual Sales$3.18 billion Price / Sales0.64 Cash Flow$2.80 per share Price / Cash Flow13.11 Book Value$14.09 per share Price / Book2.61Miscellaneous Outstanding Shares55,740,000Free Float44,422,000Market Cap$2.05 billion OptionableOptionable Beta1.18 Social Links The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NASDAQ:ASTH) was last updated on 11/3/2026 by MarketBeat.com Staff. From Our PartnersFinancial Legend: “Big trouble ahead …”Dr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution ri...Weiss Ratings | SponsoredI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredDoes your nest egg have an expiration date?A $250,000 nest egg growing at 5% a year and paying out $2,500 a month runs dry in just over a decade. Start w...Investors Alley | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astrana Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
